Hideyuki Saito

11.5k total citations
273 papers, 9.5k citations indexed

About

Hideyuki Saito is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Hideyuki Saito has authored 273 papers receiving a total of 9.5k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Oncology, 72 papers in Molecular Biology and 57 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Hideyuki Saito's work include Drug Transport and Resistance Mechanisms (86 papers), Pharmacological Effects and Toxicity Studies (46 papers) and Antibiotics Pharmacokinetics and Efficacy (39 papers). Hideyuki Saito is often cited by papers focused on Drug Transport and Resistance Mechanisms (86 papers), Pharmacological Effects and Toxicity Studies (46 papers) and Antibiotics Pharmacokinetics and Efficacy (39 papers). Hideyuki Saito collaborates with scholars based in Japan, United States and Russia. Hideyuki Saito's co-authors include Ken‐ichi Inui, Satohiro Masuda, Masahiro Okuda, Tomohiro Terada, Yumiko Urakami, Akinobu Hamada, Yukiya Hashimoto, Hiromi Tomioka, Hideyuki Motohashi and Maki Goto and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Hideyuki Saito

256 papers receiving 9.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideyuki Saito Japan 55 4.9k 2.6k 2.5k 1.3k 1.0k 273 9.5k
Yoshimichi Sai Japan 49 4.3k 0.9× 2.1k 0.8× 2.9k 1.1× 1.5k 1.2× 681 0.7× 185 8.6k
Toshiya Katsura Japan 49 3.7k 0.7× 2.0k 0.8× 2.4k 1.0× 713 0.6× 572 0.6× 144 7.0k
Johan W. Jonker Netherlands 43 5.0k 1.0× 2.3k 0.9× 4.0k 1.6× 434 0.3× 424 0.4× 102 10.3k
Jashvant D. Unadkat United States 67 5.5k 1.1× 3.8k 1.5× 2.2k 0.8× 593 0.5× 1.1k 1.0× 309 12.5k
Tomohiro Terada Japan 48 3.1k 0.6× 1.2k 0.5× 1.9k 0.7× 862 0.7× 460 0.5× 229 6.2k
Hiroyuki Kusuhara Japan 75 10.6k 2.2× 5.9k 2.3× 3.2k 1.2× 1.2k 1.0× 1.1k 1.1× 322 15.7k
Puttur D. Prasad United States 73 3.1k 0.6× 1.8k 0.7× 8.4k 3.3× 3.3k 2.6× 447 0.4× 172 15.8k
Ingolf Cascorbi Germany 57 5.6k 1.1× 3.4k 1.3× 4.1k 1.6× 335 0.3× 758 0.7× 234 13.1k
Ken‐ichi Inui Japan 75 10.5k 2.2× 5.8k 2.2× 5.3k 2.1× 2.4k 1.9× 2.0k 1.9× 502 19.7k
Gerhard Burckhardt Germany 41 2.8k 0.6× 1.3k 0.5× 2.6k 1.0× 761 0.6× 281 0.3× 164 6.3k

Countries citing papers authored by Hideyuki Saito

Since Specialization
Citations

This map shows the geographic impact of Hideyuki Saito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Saito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Saito more than expected).

Fields of papers citing papers by Hideyuki Saito

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideyuki Saito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Saito. The network helps show where Hideyuki Saito may publish in the future.

Co-authorship network of co-authors of Hideyuki Saito

This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Saito. A scholar is included among the top collaborators of Hideyuki Saito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Saito. Hideyuki Saito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oda, Kazutaka, Hirofumi Jono, & Hideyuki Saito. (2024). Optimizing Cefiderocol Dosing Through Population Pharmacokinetic/Pharmacodynamic Simulation: An Assessment of Drug Cost Reductions. Therapeutic Drug Monitoring. 47(2). 274–280.
2.
Oda, Kazutaka, Kazuaki Matsumoto, Akari Shigemi, et al.. (2024). Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application. Journal of Infection and Chemotherapy. 30(12). 1244–1251. 1 indexed citations
3.
Narita, Yuki, Hirofumi Jono, Yutaka Kakizoe, et al.. (2023). Suppression of Indoxyl Sulfate Accumulation Reduces Renal Fibrosis in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences. 24(14). 11329–11329. 9 indexed citations
4.
Oda, Kazutaka, Tomoyuki Yamada, Kazuaki Matsumoto, et al.. (2023). Model‐informed precision dosing of teicoplanin for the rapid achievement of the target area under the concentration‐time curve: A simulation study. Clinical and Translational Science. 16(4). 704–713. 3 indexed citations
5.
Oda, Kazutaka, Tomoyuki Yamada, Kazuaki Matsumoto, et al.. (2023). Model‐informed precision dosing of vancomycin for rapid achievement of target area under the concentration‐time curve: A simulation study. Clinical and Translational Science. 16(11). 2265–2275. 11 indexed citations
6.
Narita, Yuki, et al.. (2021). Suppressed Hepatic Production of Indoxyl Sulfate Attenuates Cisplatin-Induced Acute Kidney Injury in Sulfotransferase 1a1-Deficient Mice. International Journal of Molecular Sciences. 22(4). 1764–1764. 12 indexed citations
7.
Fujimoto, Yuki, Shikiko Ueno, Kazutaka Oda, et al.. (2021). Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis. Cancers. 13(22). 5674–5674.
8.
Narita, Yuki, Köichi Fukumoto, Masaki Fukunaga, et al.. (2020). Comparative Study of Constipation Exacerbation by Potassium Binders Using a Loperamide-Induced Constipation Model. International Journal of Molecular Sciences. 21(7). 2491–2491. 10 indexed citations
9.
Narita, Yuki, Yutaka Kakizoe, Yuki Kondo, et al.. (2019). Edoxaban Exerts Antioxidant Effects Through FXa Inhibition and Direct Radical-Scavenging Activity. International Journal of Molecular Sciences. 20(17). 4140–4140. 11 indexed citations
10.
Saito, Hideyuki, et al.. (2013). Emergency obstacle avoidance module for mobile robots using a laser range finder. Society of Instrument and Control Engineers of Japan. 348–353. 2 indexed citations
11.
Takao, Toshifumi, et al.. (2011). Immediate and Longitudinal Effects of Body Weight Support Treadmill Training for Patients with Chronic Hemiparesis After Stroke. 38(3). 180–187. 2 indexed citations
12.
Saito, Hideyuki, et al.. (2006). Evaluation of 11 Dacryocystorhinostomies. Practica Oto-Rhino-Laryngologica. 99(3). 211–216.
13.
Hamada, Akinobu, Akemi Tomoda, Shigehiro Ohdo, et al.. (2005). Daily expression of clock genes in whole blood cells in healthy subjects and a patient with circadian rhythm sleep disorder. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 289(5). R1273–R1279. 63 indexed citations
14.
Fujii, Junko, et al.. (2005). Importance of Introduction of Pharmaceutical Management into Clinical Path for Medicines Brought to Orthopedics Department by Patients on Hospitalization. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(11). 951–958. 9 indexed citations
15.
Saito, Hideyuki, et al.. (2005). Comparative Inter-lot Quality Investigation on Nafamostat Mesilate Preparations for Injection between Original Product and Generics. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 31(5). 391–398. 11 indexed citations
16.
Saito, Hideyuki. (2002). . Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 33(2). 25–36.
17.
Tanaka, Hajime, et al.. (2001). [Prolonged use of paclitaxel for platinum-refractory ovarian cancer--brief report].. PubMed. 28(3). 403–5. 1 indexed citations
18.
Terada, Tomohiro, Jun Wada, Hideyuki Saito, Yukiya Hashimoto, & Ken-ichi Inui. (2000). Inhibitory effect of novel oral hypoglycemic agent nateglinide (AY4166) on peptide transporters PEPT1 and PEPT2. European Journal of Pharmacology. 392(1-2). 11–17. 37 indexed citations
19.
Saito, Hideyuki, Kenichi Sato, Hiromi Tomioka, & Satoshi Dekio. (1995). In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR3355). Tubercle and Lung Disease. 76(5). 377–380. 25 indexed citations
20.
Tomioka, Hiromi, et al.. (1992). [Antimycobacterial activity of a newly synthesized fluoroquinolone, Y-26611].. PubMed. 67(7). 515–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026